As of 2025-09-18, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (26.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.07 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -476.1%.
The range of the Relative Valuation is (23.92) - (27.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.5x - 43.7x | 36.6x |
| Forward P/E multiples | 30.7x - 34.8x | 31.7x |
| Fair Price | (23.92) - (27.12) | (26.59) |
| Upside | -438.3% - -483.7% | -476.1% |
| Date | P/E |
| 2025-09-17 | -9.14 |
| 2025-09-16 | -9.08 |
| 2025-09-15 | -9.27 |
| 2025-09-12 | -9.27 |
| 2025-09-11 | -9.56 |
| 2025-09-10 | -8.99 |
| 2025-09-09 | -9.50 |
| 2025-09-08 | -9.13 |
| 2025-09-05 | -9.21 |
| 2025-09-04 | -9.21 |
| 2025-09-03 | -9.31 |
| 2025-09-02 | -9.21 |
| 2025-08-29 | -9.43 |
| 2025-08-28 | -9.50 |
| 2025-08-27 | -9.53 |
| 2025-08-26 | -9.56 |
| 2025-08-25 | -9.59 |
| 2025-08-22 | -9.89 |
| 2025-08-21 | -9.33 |
| 2025-08-20 | -9.17 |
| 2025-08-19 | -9.24 |
| 2025-08-18 | -9.04 |
| 2025-08-15 | -8.85 |
| 2025-08-14 | -8.93 |
| 2025-08-13 | -8.86 |
| 2025-08-12 | -8.39 |
| 2025-08-11 | -8.21 |
| 2025-08-08 | -7.87 |
| 2025-08-07 | -7.30 |
| 2025-08-06 | -7.03 |
| 2025-08-05 | -7.18 |
| 2025-08-04 | -7.21 |
| 2025-08-01 | -6.86 |
| 2025-07-31 | -6.90 |
| 2025-07-30 | -7.12 |
| 2025-07-29 | -7.19 |
| 2025-07-28 | -7.39 |
| 2025-07-25 | -7.32 |
| 2025-07-24 | -7.44 |
| 2025-07-23 | -7.81 |
| 2025-07-22 | -7.57 |
| 2025-07-21 | -7.35 |
| 2025-07-18 | -7.26 |
| 2025-07-17 | -7.44 |
| 2025-07-16 | -7.51 |
| 2025-07-15 | -7.39 |
| 2025-07-14 | -7.69 |
| 2025-07-11 | -7.71 |
| 2025-07-10 | -7.98 |
| 2025-07-09 | -7.99 |